Stocktoria
ArriVent BioPharma, Inc. AVBP
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-01-26
ArriVent BioPharma, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 872,011 | $30.3M | 2.05% |
| Point72 Asset Management, L.P. | 566,796 | $19.7M | 1.34% |
| MILLENNIUM MANAGEMENT LLC | 438,664 | $15.2M | 1.03% |
| BlackRock Finance, Inc. | 663,265 | $12.3M | 1.56% |
| CITADEL ADVISORS LLC | 238,342 | $8.3M | 0.56% |
| TWO SIGMA INVESTMENTS, LP | 57,804 | $2.0M | 0.14% |
| AQR CAPITAL MANAGEMENT LLC | 21,517 | $747,500 | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.